Inflammatory and oncogenic signaling converge in disease evolution of BCR-ABL-negative myeloproliferative neoplasms, clonal hematopoietic stem cell disorders characterized by gain-of-function mutation in JAK2 kinase (JAK2V617F), with highest prevalence in patients with polycythemia vera (PV). Despite the high risk, DNA-damaging inflammatory microenvironment, PV progenitors tend to preserve their genomic stability over decades until their progression to post-PV myelofibrosis/acute myeloid leukemia. Using induced pluripotent stem cells-derived CD34+ progenitor-enriched cultures from JAK2V617F+ PV patient and from JAK2 wild-type healthy control, CRISPR-modified HEL cells and patients' bone marrow sections from different disease stages, we demonstrate that JAK2V617F induces an intrinsic IFNγ- and NF-κB-associated inflammatory program, while suppressing inflammation-evoked DNA damage both in vitro and in vivo. We show that cells with JAK2V617F tightly regulate levels of inflammatory cytokines-induced reactive oxygen species, do not fully activate the ATM/p53/p21waf1 checkpoint and p38/JNK MAPK stress pathway signaling when exposed to inflammatory cytokines, suppress DNA single-strand break repair genes' expression yet overexpress the dual-specificity phosphatase (DUSP) 1. RNAi-mediated knock-down and pharmacological inhibition of DUSP1, involved in p38/JNK deactivation, in HEL cells reveals growth addiction to DUSP1, consistent with enhanced DNA damage response and apoptosis in DUSP1-inhibited parental JAK2V617F+ cells, but not in CRISPR-modified JAK2 wild-type cells. Our results indicate that the JAK2V617F+ PV progenitors utilize DUSP1 activity as a protection mechanism against DNA damage accumulation, promoting their proliferation and survival in the inflammatory microenvironment, identifying DUSP1 as a potential therapeutic target in PV.

• MeSH
• cytokiny genetika   metabolismus   MeSH
• fosfatasa 1 s dvojí specificitou genetika   MeSH
• hematopoetické kmenové buňky patologie   MeSH
• indukované pluripotentní kmenové buňky patologie   MeSH
• Janus kinasa 2 genetika   MeSH
• lidé MeSH
• mutace MeSH
• nádorové buněčné linie MeSH
• nádorové mikroprostředí MeSH
• oxidační stres * MeSH
• polycythaemia vera genetika   MeSH
• poškození DNA * MeSH
• proliferace buněk * MeSH
• reprodukovatelnost výsledků MeSH
• transkripční faktor STAT1 metabolismus   MeSH
• zánět metabolismus   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• cytokiny MeSH
• DUSP1 protein, human MeSH Prohlížeč
• fosfatasa 1 s dvojí specificitou MeSH
• JAK2 protein, human MeSH Prohlížeč
• Janus kinasa 2 MeSH
• STAT1 protein, human MeSH Prohlížeč
• transkripční faktor STAT1 MeSH